Published in J Am Acad Dermatol on April 01, 1982
Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol (2011) 1.07
Synthetic retinoids in dermatology. Can Med Assoc J (1985) 0.82
Anti-oxidant effects of retinoids on inflammatory skin diseases. Arch Dermatol Res (1986) 0.79
Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin. J Clin Aesthet Dermatol (2014) 0.77
Effect of topical application of 13-cis retinoic acid on skin of hairless rats and hairless mice. Arch Dermatol Res (1985) 0.75
Beta-lactamase activity in anaerobic bacteria. Antimicrob Agents Chemother (1976) 2.75
Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J Mol Med (Berl) (2000) 2.04
Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dyn (1994) 1.64
Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol (1992) 1.59
Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol (1998) 1.52
Autosomal monosomy in man. Complete monosomy G (21-22) in a four-and-one-half-year-old mentally retarded girl. N Engl J Med (1967) 1.47
Impetigo herpetiformis associated with hypocalcemia of congenital rickets. Arch Dermatol (1991) 1.47
What is the pathogenesis of acne? Exp Dermatol (2005) 1.40
A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl) (2000) 1.39
Tyrosinemia with plantar and palmar keratosis and keratitis. J Pediatr (1973) 1.38
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum (1995) 1.28
What is the 'true' function of skin? Exp Dermatol (2002) 1.26
A comparative study of the physicochemical properties of human keratinized tissues. Biochim Biophys Acta (1973) 1.24
Human epidermal transglutaminase. Preparation and properties. J Biol Chem (1976) 1.24
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol (1999) 1.18
Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol (1999) 1.14
The ichthyoses. Prog Med Genet (1976) 1.11
epsilon-(gamma-Glutamyl)lysine cross-links in human stratum corneum. J Biol Chem (1977) 1.08
Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol (1972) 1.07
The peeling skin syndrome. J Am Acad Dermatol (1982) 1.06
Monoclonal antibodies to anchoring fibrils for the diagnosis of epidermolysis bullosa. J Invest Dermatol (1983) 1.04
Human epidermal transamidase. J Invest Dermatol (1975) 0.96
Vertebral epidermal transamidases. Biochim Biophys Acta (1974) 0.96
Sucralose--an overview of the toxicity data. Food Chem Toxicol (2000) 0.96
Dilantin digital defects. J Am Acad Dermatol (1981) 0.92
Homeobox genes and skin development: a review. J Invest Dermatol (1993) 0.92
Skin sulfhydryl oxidase. Purification and some properties. Biochim Biophys Acta (1980) 0.91
The mechanical properties of hair. I. The dynamic sonic modulus. J Invest Dermatol (1970) 0.91
Cutaneous pseudolymphoma resulting from antigen injections. Arch Dermatol (1974) 0.90
Identification of bullous pemphigoid, pemphigus, laminin, and anchoring fibril antigens in human fetal skin. J Invest Dermatol (1985) 0.89
Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies. J Am Acad Dermatol (1997) 0.88
Organization and evolution of the human epidermal keratinocyte transglutaminase I gene. Proc Natl Acad Sci U S A (1992) 0.87
Topical application of viral vectors for epidermal gene transfer. J Invest Dermatol (1997) 0.87
Percutaneous absorption of mercury vapor by man. Arch Environ Health (1989) 0.87
Human epidermal transglutaminase. II. Immunologic properties. J Invest Dermatol (1977) 0.86
The fibrous proteins in various types of ichthyosis. J Invest Dermatol (1975) 0.86
The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol (1998) 0.86
Induction of TR4 orphan receptor by retinoic acid in human HaCaT keratinocytes. J Invest Dermatol (1999) 0.85
A model for keratinocyte gene therapy: preclinical and therapeutic considerations. Proc Assoc Am Physicians (1996) 0.84
Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications. J Am Acad Dermatol (1997) 0.84
Endogenous substrates for epidermal transglutaminase. Biochim Biophys Acta (1978) 0.84
Nutrition and the skin. Clin Dermatol (1997) 0.83
Propylene glycol. Int J Dermatol (1978) 0.83
High-molecular-weight human epidermal transglutaminase. J Invest Dermatol (1985) 0.83
Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ (1992) 0.82
Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. J Am Acad Dermatol (1992) 0.82
Mutations in epidermolysis bullosa simplex. J Invest Dermatol (1995) 0.82
Kindler's syndrome. Arch Dermatol (1978) 0.82
Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type II keratin gene cluster on chromosome 12. J Invest Dermatol (1992) 0.82
Keratohyalin protein in disorders of keratinization. J Invest Dermatol (1974) 0.82
The mechanical properties of hair. II. Chemical modifications and pathological hairs. J Invest Dermatol (1971) 0.81
Isolation of cDNA for human epidermal type I transglutaminase. J Invest Dermatol (1991) 0.81
Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases. Exp Dermatol (1992) 0.81
Epidermal type I transglutaminase (TGM1) is assigned to human chromosome 14. Cytogenet Cell Genet (1991) 0.80
Sjögren-Larsson syndrome. Diversity of cutaneous manifestations. Acta Derm Venereol (1971) 0.80
Biophysical and biochemical studies of the hair in cartilage-hair hypoplasia. Clin Genet (1973) 0.80
The structural protein of epidermis. J Invest Dermatol (1972) 0.79
Melanocytic nevi in Turner syndrome. Pediatr Dermatol (1994) 0.79
Antizyme release is an early event in ornithine decarboxylase induction by hair plucking. J Invest Dermatol (1983) 0.79
Hemolysis and lysosomal activation by solid state tyrosine. Biochem Biophys Res Commun (1975) 0.79
Tyrosine-induced skin disease. Br J Dermatol (1978) 0.79
Characterization of keratocalmin, a calmodulin-binding protein from human epidermis. J Clin Invest (1991) 0.79
Conformational changes in the -fibrous protein of epidermis. J Invest Dermatol (1973) 0.79
Modulation of epidermal growth factor receptors by retinoic acid in ME180 cells. Cancer Res (1990) 0.79
An abnormality of keratin in the harlequin fetus. Pediatrics (1970) 0.78
Human epidermal transglutaminase: stimulation by trypsin, organic solvents, and chaotropic salts. Arch Biochem Biophys (1978) 0.78
A role for leukotriene antagonists in atopic dermatitis? Am J Clin Dermatol (2001) 0.78
Localization of the Darier disease gene to a 2-cM portion of 12q23-24.1. J Invest Dermatol (1996) 0.78
The latest fashions in skin disease. Mol Med (1995) 0.77
Human epidermal transglutaminase. J Invest Dermatol (1983) 0.77
Evaluation of 13-cis retinoic acid in lamellar ichthyosis, pityriasis rubra pilaris and Darier's disease. Cutis (1980) 0.77
Studies of the density and the properties of the hair in a new inherited syndrome of hypotrichosis. Ann Hum Genet (1972) 0.77
Ornithine decarboxylase in skin. J Invest Dermatol (1980) 0.77
Localization of transglutaminase in adult chicken epidermis. Arch Dermatol Res (1978) 0.77
Human periderm: a monoclonal antibody marker. Curr Probl Dermatol (1987) 0.77
Epidermal protein synthesis in newborn rat skin. Arch Dermatol Res (1980) 0.77
The effect of 13-cis retinoic acid on epidermal lysosomal hydrolase activity in Darier's disease and pityriasis rubra pilaris. J Invest Dermatol (1980) 0.76
Sulfhydryl oxidase from rat skin. Methods Enzymol (1987) 0.76
Ornithine decarboxylase in rat skin. J Invest Dermatol (1978) 0.76
How realistic is cutaneous gene therapy? Exp Dermatol (1999) 0.76
Uniquely oriented epidermal lipid. Nature (1970) 0.76
Inhibition of rat skin ornithine decarboxylase by nitrofurazone. Arch Dermatol (1980) 0.76
Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). Exp Cell Biol (1978) 0.76
Tyrosinemia II: lessons in molecular pathophysiology. Pediatr Dermatol (1983) 0.75
Alopecia associated with fluconazole therapy. Ann Intern Med (1996) 0.75
Biological monitoring of iodine, a water disinfectant for long-term space missions. Environ Health Perspect (1995) 0.75
Decreased anchoring-fibril antigens (AF1 and AF2) in basal-cell carcinoma. Arch Dermatol Res (1985) 0.75
Haemolysis induced by tyrosine crystals: Modifiers and inhibitors. Biochem J (1976) 0.75
Propylene glycol with occlusion for treatment of ichthyosis. JAMA (1972) 0.75
Monoclonal antibodies to normal and abnormal epithelial antigens. Curr Probl Dermatol (1983) 0.75
The monkey's paw. Arch Dermatol (1986) 0.75
Steatocystoma multiplex suppurativum: treatment with isotretinoin. Cutis (1984) 0.75
Dermatologic birth defects and congenital skin disease. J Am Acad Dermatol (1984) 0.75
Genodermatoses. J Am Acad Dermatol (1987) 0.75
Immunologic properties of the -fibrous protein of human epidermis. Acta Derm Venereol (1971) 0.75
Hercules and hydra. Arch Dermatol (1987) 0.75
Recent advances in epidermal biology: relevance to epidermal malignancies. J Surg Oncol (1983) 0.75
Apologies to John Donne. Arch Dermatol (1987) 0.75
Tyrosinemia II. Int J Dermatol (1985) 0.75
Monoclonal antibodies to two different epitopes in a 30-kD CNBr peptide of the K1 and K2 keratins. J Invest Dermatol (1990) 0.75